SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies

Individuals with hematological malignancies and hematopoietic stem cell transplant (HCT) recipients are immunologically heterogenous groups with varying degrees of immunosuppression at increased risk of severe disease and mortality from SARS-CoV-2 infection. SARS-CoV-2 vaccines are key interventions...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Bin, Yanis, Ahmad, Dee, Kevin, Chappell, James D., Dulek, Daniel E., Kassim, Adetola A., Kitko, Carrie L., Thomas, Lora D., Halasa, Natasha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188822/
https://www.ncbi.nlm.nih.gov/pubmed/35752546
http://dx.doi.org/10.1016/j.blre.2022.100984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188822/
https://www.ncbi.nlm.nih.gov/pubmed/35752546
http://dx.doi.org/10.1016/j.blre.2022.100984

Ejemplares similares